Differences in the effects of cinacalcet and ethelcalcetide from the mechanism of action

Differences in the effects of cinacalcet and ethelcalcetide from the mechanism of action - Differences in the effects of cinacalcet and ethelcalcetide from the mechanism of action

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034653

Enrollment

Registered

2018-10-26

Start date

2018-10-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients with secondary hyperparathyroidism

Exclusion criteria

Exclusion criteria: Patients complicated with serious diseases such as cancer, hematological disorders, and liver cirrhosis

Design outcomes

Primary

Measure	Time frame
Differences between cinacalcet group and ethelcalcetide group by comparison of patient background, effect of Ca receptor agonist, and administered drugs	—

Countries

Japan

Contacts

Public ContactMichio Kuwahara

Saitama Tsukinomori Clinic Nephrology

kuwahara@k-naika-cl.jp0487921811

Outcome results